Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite

Inclusion Criteria: * Female ages 18-50 years * Seeking treatment of cellulite in the thigh and/or buttock areas * Area of severe cellulite on the thigh and/or buttock with an average simplified Cellulite Severity Scale at Baseline ≥ 4.0 (Table 2) * Having at least one dimple, or ridge-depression, in the treatment area, with a depth of approximately 5 mm or greater. * Stable weight nominally +/- 5% for at least the past 6 months. * Body Mass Index (B.M.I.) is ≤ 30 * Participant will not have had invasive or energy based cellulite treatments (liposuction, subcision, RF, laser, ESWT, etc.) for the prior 12 months. * Participant will not have used topical based cellulite treatments for prior 6 months and will not use during the trial. * Will not undergo any other cellulite treatments for a period of 12 months following RAP treatment. * Participant is willing to participate in study and adhere to follow-up schedule * Participant is able to read and comprehend English * Participant has completed the Informed Consent Form Exclusion Criteria: * Participant is unwilling to have research photos taken of treatment areas in the presence of Sponsor's researchers. * Participant is unwilling to have RAP treatment provided in the presence of Sponsor's researchers. * Participant is pregnant or planning to become pregnant during the duration of the study. * Has atrophic scars, or has a history of atrophic scars or keloids. * Tattoo or former tattoo at or near treatment area. * Metal or plastic implants in the area of the treatment (vascular stent, or implants in the hips, knees, etc.). * Active electronic implants such as pacemakers, defibrillators, cochlear implants, nerve/brain stimulators, drug pump, etc. * Medical disorder that would hinder the wound healing or immune response (no blood disorder, inflammatory disease, etc.). * History of coagulopathy(ies) and/or on anticoagulant medication. * Skin disorders (skin infections or rashes, extensive scarring, psoriasis, etc.) in the treatment area. * Current smoker. * Any surgical procedure in the prior 3 months, or planned during the duration of the study.